SCHEMBL30675668

SCHEMBL30675668

COC(=O)c1cncc(Cc2ccc(Cl)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.50
▸ ALPL P05186 2/20 0.46
▸ DRD2 P14416 1/20 0.46
▸ TBXA2R P21731 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ P2RX3 P56373 5/20 0.45
▸ RAB9A P51151 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ PTGER1 P34995 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KDM5A P29375 1/20 0.42
▸ KDM5B Q9UGL1 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961945 1.00 ATM (0.50) ATMALPLDRD2TBXA2RMAPT
SCHEMBL16881118 0.86 LOXL2 (0.59) ATMMAPTALDH1A1CYP11B1CYP11B2
SCHEMBL23120562 0.85 ATM (0.53) ATMALDH1A1LMNARAB9ANPC1
SCHEMBL16880649 0.82 KMT2A (0.47) ATMMAPTKMT2AALDH1A1RAB9A
SCHEMBL7411710 0.81 NPC1 (0.60) DRD2TBXA2RMAPTMEN1KMT2A
SCHEMBL16881124 0.81 ATM (0.46) ATMALDH1A1RAB9ACYP11B1CYP11B2
SCHEMBL16880735 0.81 KLKB1 (0.48) ATMALDH1A1CYP11B1CYP11B2
SCHEMBL16880998 0.80 SMN1; SMN2 (0.51) ATMMAPTKMT2AALDH1A1LMNA
SCHEMBL16881389 0.80 ATM (0.44) ATMMAPTALDH1A1CYP11B1CYP11B2
SCHEMBL16881141 0.80 ATM (0.44) ATMMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 — — CN disclosed
Send feedback